Company Overview
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals across the United States, with a specialized focus on small animal general practice hospitals that serve companion pets, including canine, feline, and equine breeds. Beyond general practice, the company provides surgical services that encompass soft tissue procedures. The firm operates within the Consumer Cyclical sector, specifically in the Personal Services industry, a classification that suggests its revenue streams are sensitive to discretionary spending patterns and economic cycles affecting pet ownership. The company's current market capitalization stands at $4.05M, supported by annual revenue of $15.56M and an employee base of 113 individuals. These valuation and revenue figures indicate that Inspire Veterinary Partners is a micro-cap entity with a relatively small operational footprint compared to larger national veterinary chains, positioning it as a niche player in the broader healthcare services landscape.
Financial Health
The company reported total revenue of $15.56M for the trailing twelve months, yet this revenue generated a net income loss of $-11,942,600 and an EBITDA of $-7,723,924. The substantial gap between the positive revenue of $15.56M and the significant net loss of $-11.94M reveals a highly expansive cost structure where operating expenses and losses heavily outweigh earnings, resulting in a profit margin of -76.8%. Free cash flow for the period was $-129,976, indicating that the company is currently consuming cash rather than generating it, which limits its financial flexibility for internal expansion or debt repayment without external capital injection. The gross margin stands at 19.4%, suggesting that after direct costs of services, the company retains a modest portion of revenue, while the operating margin of -45.6% highlights severe inefficiencies or high fixed costs in its overhead structure. Regarding liquidity and leverage, the company holds $2.91M in cash against $17.12M in debt, creating a net debt position that is more than six times its liquid assets. This imbalance is further emphasized by a debt-to-equity ratio of 410.61, signifying an extremely leveraged balance sheet where equity is minimal relative to obligations. The current ratio is 0.39, which indicates that current assets are less than half of current liabilities, pointing to potential short-term liquidity challenges in meeting immediate financial obligations. Return on Equity is -331.8% and Return on Assets is -24.0%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate profit, as both return measures are deeply negative.
Valuation Assessment
The trailing P/E ratio and forward P/E ratio are both listed as N/A, which implies that traditional earnings-based valuation metrics are not applicable due to the company's consistent lack of positive net income. Consequently, the price-to-book ratio is 0.05, indicating that the market values the company at only 5% of its book value, a stark discount that often signals deep value concerns or significant perceived risks regarding asset quality and future profitability. Alternative valuation metrics such as the price-to-sales ratio of 0.26 and an EV/EBITDA of -1.87 suggest that the market is pricing the stock based on revenue multiples rather than earnings power, reflecting the absence of current profitability. The stock's trading range over the last year is defined by a 52-week high of $3.32 and a 52-week low of $0.01, placing the current market price at the extreme lower end of this historical spectrum. The beta value is -0.45, a negative figure that is atypical for equities and suggests an inverse correlation to the broader market or extreme volatility where the stock moves in the opposite direction of market indices, complicating standard volatility comparisons.
Growth & Income
Revenue growth year-over-year is recorded at 6.6%, while earnings growth is N/A due to the absence of positive earnings in the prior period. The absence of positive earnings growth prevents a direct comparison between earnings and revenue expansion rates, but the positive revenue growth indicates that top-line business is expanding despite the lack of bottom-line profitability. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning that any available cash or retained earnings are being retained within the company rather than distributed to shareholders. This reinvestment strategy is a necessity for a cash-negative company attempting to stabilize its operations and potentially turn the business model profitable before considering any form of capital distribution to investors. The overall growth and income profile is characterized by positive revenue expansion paired with structural losses and zero dividend distribution, presenting a high-risk scenario where capital appreciation is the only potential return mechanism available to shareholders in the current fiscal environment.